Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma | Zendy

Leonard B. Bacharier | Zendy; Jorge Máspero | Zendy; Constance H. Katelaris | Zendy; Alessandro Fiocchi | Zendy; Rémi Gag | Zendy; I. de Mir | Zendy; Neal Jain | Zendy; Lawrence Sher | Zendy; Xuezhou Mao | Zendy; Dongfang Liu | Zendy; Yi Zhang | Zendy; Asif Khan | Zendy; Upender Kapoor | Zendy; Faisal A. Khokhar | Zendy; Paul J. Rowe | Zendy; Yamo Deniz | Zendy; Marcella Ruddy | Zendy; Elizabeth Laws | Zendy; Naimish Patel | Zendy; David M. Weinreich | Zendy; George D. Yancopoulos | Zendy; Nikhil Amin | Zendy; Leda Mannent | Zendy; David J. Lederer | Zendy; Megan Hardin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

Author(s) -

Leonard B. Bacharier,

Jorge Máspero,

Constance H. Katelaris,

Alessandro Fiocchi,

Rémi Gag,

I. de Mir,

Neal Jain,

Lawrence Sher,

Xuezhou Mao,

Dongfang Liu,

Yi Zhang,

Asif Khan,

Upender Kapoor,

Faisal A. Khokhar,

Paul J. Rowe,

Yamo Deniz,

Marcella Ruddy,

Elizabeth Laws,

Naimish Patel,

David M. Weinreich,

George D. Yancopoulos,

Nikhil Amin,

Leda Mannent,

David J. Lederer,

Megan Hardin

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2106567

Subject(s) - dupilumab , asthma , medicine , pediatrics , immunology

Children with moderate-to-severe asthma continue to have disease complications despite the receipt of standard-of-care therapy. The monoclonal antibody dupilumab has been approved for the treatment of adults and adolescents with asthma as well as with other type 2 inflammatory diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research